SLE vs CPB โ Head-to-Head Terminal
6-dimension institutional benchmarking across valuation, multi-year operating margins, normalized momentum, and dealer gamma corridors.
Pillar 1 Executive Scorecard & Category Winner Tally
CPB Captures Institutional Edge (3โ1 Pillars ยท 6โ4 Matrix Metrics)
Tradestie Institutional Equity Comparison Engine assigns the overall head-to-head edge to The Campbell's Company Common Stock (CPB) driven by superior Valuation, Growth & Margin, Options & Structure while SLE counters with relative strength in Momentum & Technical. Fundamentally, SLE trades at N/M Forward P/E with -121.0% operating margin (+0.3% YoY revenue) versus CPB at 12.3x Forward P/E and 12.4% operating margin (-7.9% YoY). In options structure, SLE sits in UNCLASSIFIED (N/A IV; Dealer Gamma Walls on Pro) against CPB sits in SURGE (14th %ile IV; Dealer Gamma Walls on Pro).
Pillar 2 Normalized Relative Return Performance (% Indexed to 0%)
Pillar 3 Multi-Year Annual Revenue & Operating Margin Trajectory (USD)
| Period | SLE Revenue | CPB Revenue | SLE Op. Margin | CPB Op. Margin | Margin Edge |
|---|---|---|---|---|---|
| FY2019 | $0M | $8.11B | -1916.1% | 12.1% | CPB |
| FY2020 | $0M | $8.69B | -908.1% | 12.7% | CPB |
| FY2021 | $10M | $8.48B | -214.9% | 18.2% | CPB |
| FY2022 | $20M | $8.56B | -431.8% | 13.6% | CPB |
| FY2023 | $30M | $9.36B | -130.9% | 14.0% | CPB |
| FY2024 | $20M | $9.64B | -103.5% | 10.4% | CPB |
| FY2025 | $10M | $10.2B | -115.1% | 11.0% | CPB |
| FY2026 | N/A | $9.74B | N/A | 8.7% | CPB |
Pillar 4 Head-to-Head Fundamental & Valuation Matrix
| Institutional Metric | SLE | CPB | Criterion | Row Winner |
|---|---|---|---|---|
| Market Capitalization Scale | $13.2M | $6.8B | Larger Scale | CPB |
| Trailing P/E Ratio Valuation | 0.1x | 17.4x | Lower Multiple | SLE |
| Forward P/E Ratio Valuation | N/M | 12.3x | Lower Multiple | CPB |
| Revenue Growth (YoY) Growth | +0.3% | -7.9% | Higher Growth | SLE |
| Operating Margin (TTM) Profitability | -121.0% | 12.4% | Higher Margin | CPB |
| Net Profit Margin Profitability | -190.3% | 4.1% | Higher Margin | CPB |
| Return on Equity (ROE) Capital Efficiency | -504.0% | 10.1% | Higher ROE | CPB |
| 52-Week Range Position Momentum | 42% ($0โ$9) | 36% ($19โ$32) | Stronger Trend | SLE |
| Beta / 30D Volatility Risk Regime | 0.09ฮฒ ยท 90% Vol | -0.34ฮฒ ยท 44% Vol | Lower Realized Risk | CPB |
| Unified Institutional Score Composite Signal | 62.1 / 100 (BUY) | 32.0 / 100 (SELL) | Higher Composite | SLE |